Biosimilars LatAm – Global 2025
This forum brings together high-level executives from pharmaceutical manufacturers, regulatory entities, and industry associations to discuss opportunities for greater access to biosimilars in Latin America on a global stage. Through dynamic presentations and panel discussions, participants will explore advancements in scalability, quality, and regulatory strategies. The event highlights Brazil’s leadership in pharmaceutical production, Colombia’s biotech potential, and Mexico’s attractiveness for investors, positioning the region as a strategic partner for Asia and Europe.
Key Objectives:
– Highlight Brazil’s leadership in pharmaceutical production by showcasing lessons from local development programs, regulatory expansion, and unique opportunities for investors.
– Explore Colombia’s initiatives to build local biotech capabilities, emphasizing infrastructure, talent, and local production as a strategic hub for biosimilars in Latin America.
– Present Mexico as an attractive market for biosimilar investors, focusing on regulatory reforms, public-private collaborations, and fiscal incentives that foster a favorable investment environment.
Who will
you meet?
More than:
Participants
Companies
HCPs
Patients
Academy
Investors
Institutions
Associations
Service Providers
Government Agencies
Industry Executives from Latam
- Biosimilars
- Biobetters
- Biotechnology
- Biotherapeutics
- Analytical science
- Regulatory compliance
- Quality Control
- Clinical immunology
- Scientific Affairs
- Pharmacovigilance
- Research
- Regulatory
- Business Development
- Marketing
Speaker Board in 2025
Fernando Mejia
Partner
Lisandro Herrera
Legal Executive
Hugo Carrasco
Founder & Partner
Srinivas Komala
Country Manager Brazil
José Avalos Rogel
General Director
Cristiano Gonçalves
Director of Innovation and Tech Licensing
Perla Villani Borges
Business Development Manager
Ximena Marcela Bonilla Forero
Photo Gallery from Previous Events
Testimonials
-
”What you and your team are doing to advance the biosimilars industry is nothing short of inspiring. The dedication, vision, and passion that drive your work not only create a platform for meaningful discussions but also pave the way for real-world solutions that can positively impact countless lives around the globe. I deeply admire the effort and commitment you all bring to making this a space for innovation and collaboration.”
Srinivas Komala, Country Manager at MSN Labs, Brazil
-
”It was an excellent opportunity to hear what the authorities industry, even sometimes what our competitors or other providers have to say about the topic.”
Alison Bascou, Sr. Regulatory Director at BD, France
-
"I think it's being an interesting event. Wherever there's discussion at top level, wherever there's respect. wherever there's an open forum, science can advance. It's very important to keep patient's well-being in mind and I think this forum allows that."
Jaime Uribe, CEO At PROBIOMED
-
“The strength of the biosimilar industry in our region is very encouraging. It seems to me this event is the propitious forum to share experiences and it is great.”
Tammy Boggiano Ayo, Process Development Director at CIM, Cuba
-
“It showed a broad picture, from a highly technical perspective up to a commercial viewpoint. It is not easy to get that in such a short period of time.”
Santiago Salguero, Executive Director at Pharmaceutical Association of Ecuador
-
“For companies like those I work for, i.e. suppliers to the pharmaceutical industry, this has been a great opportunity to see our clients’ perspective and above all to identify the major trends determining the future of biosimilars.”
Mauricio Roberto Hernández Morales, Key Account and Business Developer Manager at BD Mexico